489 related articles for article (PubMed ID: 27646470)
1. Understanding how long-acting β
Newton R; Giembycz MA
Br J Pharmacol; 2016 Dec; 173(24):3405-3430. PubMed ID: 27646470
[TBL] [Abstract][Full Text] [Related]
2. Long-Acting
Rider CF; Altonsy MO; Mostafa MM; Shah SV; Sasse S; Manson ML; Yan D; Kärrman-Mårdh C; Miller-Larsson A; Gerber AN; Giembycz MA; Newton R
Mol Pharmacol; 2018 Sep; 94(3):1031-1046. PubMed ID: 29959223
[TBL] [Abstract][Full Text] [Related]
3. Benefit-risk assessment of long-acting beta2-agonists in asthma.
Jackson CM; Lipworth B
Drug Saf; 2004; 27(4):243-70. PubMed ID: 15003036
[TBL] [Abstract][Full Text] [Related]
4. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
Ni CM; Greenstone IR; Ducharme FM
Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
[TBL] [Abstract][Full Text] [Related]
5. Inhaled long-acting β2 agonists enhance glucocorticoid receptor nuclear translocation and efficacy in sputum macrophages in COPD.
Haque R; Hakim A; Moodley T; Torrego A; Essilfie-Quaye S; Jazrawi E; Johnson M; Barnes PJ; Adcock IM; Usmani OS
J Allergy Clin Immunol; 2013 Nov; 132(5):1166-73. PubMed ID: 24070494
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of long-acting beta2-adrenoceptor agonism.
Lipworth BJ
Br J Clin Pharmacol; 2002 Sep; 54(3):231-45. PubMed ID: 12236842
[TBL] [Abstract][Full Text] [Related]
7. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids.
Barnes PJ
Eur Respir J; 2002 Jan; 19(1):182-91. PubMed ID: 11843317
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy of long-acting beta2-adrenoceptor agonists and corticosteroids for asthma.
Chung KF; Adcock IM
Treat Respir Med; 2004; 3(5):279-89. PubMed ID: 15606218
[TBL] [Abstract][Full Text] [Related]
9. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
[TBL] [Abstract][Full Text] [Related]
10. Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β
Buhl R; FitzGerald JM; Busse WW
Respir Med; 2018 Oct; 143():82-90. PubMed ID: 30261998
[TBL] [Abstract][Full Text] [Related]
11. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2011 May; (5):CD003137. PubMed ID: 21563136
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome-Level Interactions between Budesonide and Formoterol Provide Insight into the Mechanism of Action of Inhaled Corticosteroid/Long-Acting
Mostafa MM; Rider CF; Wathugala ND; Leigh R; Giembycz MA; Newton R
Mol Pharmacol; 2021 Mar; 99(3):197-216. PubMed ID: 33376135
[TBL] [Abstract][Full Text] [Related]
13. The long-acting β2 -adrenoceptor agonist, indacaterol, enhances glucocorticoid receptor-mediated transcription in human airway epithelial cells in a gene- and agonist-dependent manner.
Joshi T; Johnson M; Newton R; Giembycz MA
Br J Pharmacol; 2015 May; 172(10):2634-53. PubMed ID: 25598440
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
Sin DD; Man SF
Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
[TBL] [Abstract][Full Text] [Related]
15. Superiority of combined phosphodiesterase PDE3/PDE4 inhibition over PDE4 inhibition alone on glucocorticoid- and long-acting β2-adrenoceptor agonist-induced gene expression in human airway epithelial cells.
BinMahfouz H; Borthakur B; Yan D; George T; Giembycz MA; Newton R
Mol Pharmacol; 2015 Jan; 87(1):64-76. PubMed ID: 25324049
[TBL] [Abstract][Full Text] [Related]
16. A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids.
Giembycz MA; Kaur M; Leigh R; Newton R
Br J Pharmacol; 2008 Mar; 153(6):1090-104. PubMed ID: 18071293
[TBL] [Abstract][Full Text] [Related]
17. Assessment of anti-inflammatory effect from addition of a long-acting beta-2 agonist to inhaled corticosteroid.
Shimoda T; Obase Y; Kishikawa R; Mukae H; Iwanaga T
Allergy Asthma Proc; 2016 Sep; 37(5):387-93. PubMed ID: 27657522
[TBL] [Abstract][Full Text] [Related]
18. Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells.
Kaur M; Chivers JE; Giembycz MA; Newton R
Mol Pharmacol; 2008 Jan; 73(1):203-14. PubMed ID: 17901197
[TBL] [Abstract][Full Text] [Related]
19. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.
Main C; Shepherd J; Anderson R; Rogers G; Thompson-Coon J; Liu Z; Hartwell D; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
Health Technol Assess; 2008 May; 12(20):1-174, iii-iv. PubMed ID: 18485272
[TBL] [Abstract][Full Text] [Related]
20. Advances in asthma and COPD treatment: combination therapy with inhaled corticosteroids and long-acting beta 2-agonists.
Miller-Larsson A; Selroos O
Curr Pharm Des; 2006; 12(25):3261-79. PubMed ID: 17020533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
